Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1510)
|
Core Tip (1208)
|
Full Article (HTML) (12703)
|
Figures (1-3) (186)
|
Tables (1-5) (204)
|
Full Article (PDF)-1451K (1134)
|
Peer-Review Report-94K (326)
|
Answering Reviewers-72K (249)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (54)
|
Total Visits (23255)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1496)
|
Core Tip (1197)
|
Full Article (HTML) (7870)
|
Figures (1-1) (258)
|
Tables (1-3) (167)
|
Full Article (PDF)-1210K (629)
|
Peer-Review Report-98K (277)
|
Answering Reviewers-99K (227)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15169)
|
Similar Articles (148)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1365)
|
Core Tip (1183)
|
Full Article (HTML) (8673)
|
Figures (1-4) (460)
|
Tables (1-1) (155)
|
Full Article (PDF)-1374K (976)
|
Peer-Review Report-105K (262)
|
Answering Reviewers-58K (322)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (16650)
|
Similar Articles (6)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1203)
|
Core Tip (1167)
|
Full Article (HTML) (6128)
|
Figures (1-3) (247)
|
Full Article (PDF)-2317K (703)
|
Peer-Review Report-102K (262)
|
Answering Reviewers-250K (325)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12826)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1009)
|
Core Tip (872)
|
Full Article (HTML) (4213)
|
Figures (1-1) (159)
|
Tables (1-4) (166)
|
Full Article (PDF)-1455K (605)
|
Peer-Review Report-129K (151)
|
Answering Reviewers-81K (173)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (9881)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned
World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1119)
|
Core Tip (868)
|
Full Article (HTML) (3298)
|
Figures (1-1) (199)
|
Tables (1-1) (171)
|
Full Article (PDF)-2534K (449)
|
Peer-Review Report-98K (218)
|
Answering Reviewers-19K (150)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9756)
|
Similar Articles (4)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1387)
|
Core Tip (1048)
|
Full Article (HTML) (7331)
|
Figures (1-2) (224)
|
Tables (1-1) (124)
|
Full Article (PDF)-1376K (608)
|
Peer-Review Report-116K (296)
|
Answering Reviewers-78K (293)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (16707)
|
Similar Articles (59)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1312)
|
Core Tip (1173)
|
Full Article (HTML) (6264)
|
Figures (1-2) (120)
|
Tables (1-1) (119)
|
Full Article (PDF)-2415K (422)
|
Peer-Review Report-106K (336)
|
Answering Reviewers-72K (203)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (12571)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1191)
|
Core Tip (1083)
|
Full Article (HTML) (4769)
|
Figures (1-1) (157)
|
Full Article (PDF)-1040K (513)
|
Peer-Review Report-104K (251)
|
Answering Reviewers-60K (198)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11141)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1263)
|
Core Tip (1256)
|
Full Article (HTML) (5693)
|
Figures (1-2) (186)
|
Tables (1-1) (122)
|
Full Article (PDF)-4747K (698)
|
Peer-Review Report-116K (299)
|
Answering Reviewers-128K (283)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (14997)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1001)
|
Core Tip (814)
|
Full Article (HTML) (3595)
|
Tables (1-1) (157)
|
Full Article (PDF)-1054K (326)
|
Peer-Review Report-106K (232)
|
Answering Reviewers-75K (159)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (8859)
|
Similar Articles (16)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1170)
|
Core Tip (922)
|
Full Article (HTML) (5715)
|
Tables (1-2) (146)
|
Full Article (PDF)-872K (569)
|
Peer-Review Report-82K (262)
|
Answering Reviewers-100K (226)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (12876)
|
Similar Articles (28)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1007)
|
Core Tip (779)
|
Full Article (HTML) (1957)
|
Figures (1-2) (111)
|
Tables (1-1) (128)
|
Full Article (PDF)-1053K (281)
|
Peer-Review Report-98K (248)
|
Answering Reviewers-31K (150)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9755)
|
Similar Articles (713)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1164)
|
Core Tip (1021)
|
Full Article (HTML) (5907)
|
Tables (1-4) (191)
|
Full Article (PDF)-1067K (528)
|
Peer-Review Report-118K (252)
|
Answering Reviewers-113K (263)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12568)
|
Similar Articles (69)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1163)
|
Core Tip (907)
|
Full Article (HTML) (7844)
|
Figures (1-1) (153)
|
Tables (1-2) (144)
|
Full Article (PDF)-1014K (387)
|
Peer-Review Report-80K (231)
|
Answering Reviewers-67K (185)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (14311)
|
Similar Articles (196)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open